817 results match your criteria Annals of cardiothoracic surgery[Journal]


Robotic-assisted thoracoscopic surgery (RATS) lobectomy.

Ann Cardiothorac Surg 2019 Mar;8(2):296-299

Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.02.07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462556PMC

Management of robotic bleeding complications.

Ann Cardiothorac Surg 2019 Mar;8(2):292-295

Division of Thoracic Surgery, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.02.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462551PMC

Robotic thymectomy for myasthenia gravis.

Ann Cardiothorac Surg 2019 Mar;8(2):288-291

Department of Thoracic Surgery, Group Florence Nightingale Hospitals, Istanbul, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.02.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462546PMC

Four-arm robotic sleeve right upper lobectomy.

Authors:
Marion Durand

Ann Cardiothorac Surg 2019 Mar;8(2):286-287

Ramsay Générale de Santé, Thoracic Unit, Hôpital Privé d'Antony, Antony, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.11.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462548PMC

Right robotic-assisted thoracoscopic lower lobectomy.

Ann Cardiothorac Surg 2019 Mar;8(2):279-285

Robotic Multispecialty Centre for Surgery, Minimally Invasive and Robotic Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.

The right lower lobectomy is considered one of the easier resection operations performed by an open technique. The posterior approach for the video-assisted thoracoscopic surgery (VATS) version of this is similar, as instruments and staplers pass up the fissure. When moving to the robotic platform with the camera and instruments entering from caudal ports, the equal view of the lobe, fissure and both hila allow for a more balanced operation. Read More

View Article

Download full-text PDF

Source
http://www.annalscts.com/article/view/16593/16919
Publisher Site
http://dx.doi.org/10.21037/acs.2019.03.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462557PMC
March 2019
3 Reads

Disruptive technology will transform what we think of as robotic surgery in under ten years.

Authors:
Joel Dunning

Ann Cardiothorac Surg 2019 Mar;8(2):274-278

Department of Cardiothoracic Surgery, James Cook University Hospital, Middlesbrough, UK.

What is currently described as 'robotic surgery' will undergo a transformation as rapid as the transformation from Kodak film cameras to digital cameras, from Nokia phones to iPhones, from listening to music on tape to CD then to digital downloading, and the transformation that is shortly to come from petrol cars into electric cars. We are only at the very infancy of what is currently termed robotic surgery, but in reality, is in fact just computer-assisted, instrument-controlled surgery. This article will describe the current state of robotic surgery and will then go on to look at why we will hardly recognize the surgical world in ten years' time, as novel, disruptive technology transforms our specialty. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.03.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462560PMC

How to get the most out of your trainees in robotic thoracic surgery-"the coachability languages".

Ann Cardiothorac Surg 2019 Mar;8(2):269-273

Department of Cardiothoracic Surgery, New York University Langone Health, New York, NY, USA.

We are honored to have been invited to write this piece entitled, "". Perhaps a better question is "". As surgeons, we must recognize some of the subtle differences in alignment between ourselves and our trainees, appreciate the value of the trainee within our profession, understand that there is variability to the coaching style that each trainee best responds to, and acknowledge that the success of the people we train-which may be our only true legacy-depends on how we engage and inspire them. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462558PMC
March 2019
1 Read

Anesthesia for robotic thoracic surgery.

Ann Cardiothorac Surg 2019 Mar;8(2):263-268

Department of Cardiothoracic Anesthesia, Freeman Hospital, Newcastle Upon Tyne, UK.

Robotically assisted thoracic surgery (RATS) to date is performed as a small proportion of thoracic surgical procedures and only at a few centres, but is rapidly gaining more widespread interest. In this article, we present our anesthetic perspective of planning and performing RATS and highlight specific points to consider when managing these patients. Read More

View Article

Download full-text PDF

Source
http://www.annalscts.com/article/view/16566/16917
Publisher Site
http://dx.doi.org/10.21037/acs.2018.12.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462555PMC
March 2019
2 Reads

Working towards clinical effectiveness-a multi-disciplinary approach to robotic surgery.

Ann Cardiothorac Surg 2019 Mar;8(2):255-262

Department of Nursing, Midwifery and Health, Northumbria University, Coach Lane Campus, Newcastle-Upon-Tyne, UK.

The importance of a multi-disciplinary team (MDT) approach to conventional surgical techniques has strong empirical support. The MDT approach to robotic-assisted surgery (RAS) has not been clearly defined, which encourages prospectively poor MDT performance. Poor performance of the MDT approach, allied to the constant evolution of technology-assisted surgery, can generate unacceptable operative and patient outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.02.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462554PMC

Resource implications of robotic thoracic surgery: what are the wider issues?

Ann Cardiothorac Surg 2019 Mar;8(2):250-254

Freeman Hospital, Newcastle Upon Tyne, UK.

The benefits of minimally invasive thoracic surgery are well documented when compared to the use of standard thoracotomy. Much controversy exists, however, regarding the resource implications when using robot-assisted thoracic surgery (RATS), especially when compared to video-assisted thoracoscopic surgery (VATS). Much of the costs attributed to a particular approach center around the frequency and severity of the complications that may arise. Read More

View Article

Download full-text PDF

Source
http://www.annalscts.com/article/view/16559/16915
Publisher Site
http://dx.doi.org/10.21037/acs.2018.11.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462561PMC
March 2019
4 Reads

Robotic thoracic surgery in inflammatory and infective diseases.

Ann Cardiothorac Surg 2019 Mar;8(2):241-249

Department of Minimally Invasive Thoracic Surgery, Medanta, The Medicity, Gurgaon, India.

Tuberculosis and inflammatory conditions are endemic in India and South-East Asia. They cause intense inflammatory reactions and adhesions, thus making surgical resection difficult. In 2009, we installed an intuitive da Vinci HDSi robot to perform our surgery as a part of a robotic thoracic surgery unit. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.02.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462553PMC
March 2019
1 Read

Robot-assisted thoracic surgery in Colombia: a multi-institutional initial experience.

Ann Cardiothorac Surg 2019 Mar;8(2):233-240

Department of Surgical Oncology, Instituto Nacional de Cancerología, Universidad Militar Nueva Granada, Bogotá, Colombia.

Background: Robotic assisted videothoracoscopic surgery (RVATS) adoption has increased worldwide from 3.4% in 2010 to 17.5% in 2015. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.03.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462562PMC

Robotic lobectomy for lung cancer: initial experience of a single institution in Korea.

Ann Cardiothorac Surg 2019 Mar;8(2):226-232

Department of Anesthesiology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Background: Robotic surgery is known to have several advantages including magnified three-dimensional vision and angulation of the surgical instruments. To evaluate the feasibility and efficiency of robotic lobectomy in the treatment of lung cancer, we analyzed the outcomes of our initial experiences with robotic lobectomy at a single institution in Korea.

Methods: Eighty-seven patients with lung cancer underwent robotic lobectomy (robotic group: 34 patients) and video-assisted thoracic surgery (VATS) lobectomy (VATS group: 53 patients) between 2011 and 2016 at our hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.02.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462559PMC
March 2019
1 Read

Extended thoracic lymph node dissection in robotic-assisted minimal invasive esophagectomy (RAMIE) for patients with superior mediastinal lymph node metastasis.

Ann Cardiothorac Surg 2019 Mar;8(2):218-225

Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Background: Robot-assisted surgery may have a role in improving oncological outcomes in esophagectomy. Especially in the anatomical areas in the chest that are more difficult to reach in open surgery (including the superior mediastinum). The dexterity of the robotic instruments aid in performing a more extensive nodal dissection and the precision and detailed vision of the robotic system potentially improves staging, oncological outcomes and reduces complications (i. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.01.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462563PMC
March 2019
1 Read

The evolution of robotic thoracic surgery.

Ann Cardiothorac Surg 2019 Mar;8(2):210-217

Minimally Invasive and Robotic Thoracic Surgery, Robotic Multispecialty Center of Surgery, University Hospital of Pisa, Pisa, Italy.

Robotic surgery has the features to represent the future of surgery, considering the rapid evolution of its technology and the resulting in the surgical field. In the last years, the robotic technique in thoracic surgery has progressively become widespread in the word, particularly for the treatment of the mediastinal and pulmonary lesions. The development of technology in the robotic system has been associated with the improvement of intraoperative and postoperative results. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.03.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462549PMC

Training in robotic thoracic surgery-the European way.

Ann Cardiothorac Surg 2019 Mar;8(2):202-209

Department of General Surgery, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands.

The increasing demand for robot-assisted thoracic surgery (RATS) in Europe requires a structured and standardized training module. Until now, Intuitive Surgical Inc. (Sunnyvale, CA, USA) has delivered the only available robotic surgery platform. Read More

View Article

Download full-text PDF

Source
http://www.annalscts.com/article/view/16558/16909
Publisher Site
http://dx.doi.org/10.21037/acs.2018.11.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462552PMC
March 2019
2 Reads

Understanding the financial cost of robotic lobectomy: calculating the value of innovation?

Ann Cardiothorac Surg 2019 Mar;8(2):194-201

Division of Thoracic Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Background: The advantages of a minimally-invasive surgical approach compared to conventional open thoracotomy for lung resection have been previously described. While robot-assisted thoracoscopic surgery (RATS) has shown comparable clinical outcomes for lobectomy as compared with video-assisted thoracic surgery (VATS), the cost and inherent value associated with the robotic technology remains a main concern.

Methods: We conducted a systematic review of the literature on the cost of RATS lobectomy using studies published prior to December 2017 on MEDLINE and EMBASE. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.05.18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462550PMC

A systematic review of robotic versus open and video assisted thoracoscopic surgery (VATS) approaches for thymectomy.

Ann Cardiothorac Surg 2019 Mar;8(2):174-193

Department of Thoracic Surgery, Mater Misericordiae University Hospital, Eccles St., Dublin, Ireland.

Background: Median sternotomy has been the most commonly used approach for thymectomy to date. Recent advances in video-assisted thoracoscopic surgery (VATS) and robotic access with CO insufflation techniques have allowed more minimally invasive approaches. However, prior reviews have not compared robotic to both open and VATS thymectomy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.02.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462547PMC

Weaning from veno-arterial extra-corporeal membrane oxygenation: which strategy to use?

Ann Cardiothorac Surg 2019 Jan;8(1):E1-E8

Department of Intensive Care Cnit, Hôpital Européen Georges Pompidou (HEGP) Assistance Publique-Hôpitaux de Paris (APHP) and Université Paris Descartes, Paris, France.

Refractory cardiogenic shock patients may be rescued by veno-arterial extracorporeal membrane oxygenation (VA ECMO). After a few days of mechanical assistance, the device can sometimes be successfully removed if the patient has partially or fully recovered from the condition that required the use of ECMO. The percentage of patients with refractory cardiogenic shock who are successfully weaned from ECMO varies from 31% to 76%. Read More

View Article

Download full-text PDF

Source
http://www.annalscts.com/article/view/16577/16893
Publisher Site
http://dx.doi.org/10.21037/acs.2018.08.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379199PMC
January 2019
4 Reads

Preoperative and intraoperative extracorporeal membrane oxygenation adoption for long-term left ventricular assist device implantation.

Ann Cardiothorac Surg 2019 Jan;8(1):167-169

Department of Cardiovascular Surgery, University Hospital of Düsseldorf, Heinrich-Heine University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.10.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379203PMC
January 2019

Double, triple and quadruple cannulation for veno-arterial extracorporeal membrane oxygenation support: is there a limit?

Ann Cardiothorac Surg 2019 Jan;8(1):151-159

Department of Cardiovascular Surgery and Transplantation, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Each cannulation strategy for venoarterial extracorporeal membrane oxygenation (VA ECMO) has distinct benefits and drawbacks. In this article, various cannulation strategies including their indications are discussed. The gold standard for cannulation involves peripheral, percutaneous double cannulation utilizing the patient's femoral vein and artery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.01.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379187PMC
January 2019
1 Read

Short-term mechanical circulatory support as bridge to heart transplantation: paracorporeal ventricular assist device as alternative to extracorporeal life support.

Ann Cardiothorac Surg 2019 Jan;8(1):143-150

Cardiothoracic Department, University Hospital of Udine, Udine, Italy.

Extracorporeal life support (ECLS) is generally considered to be the treatment of choice for bridging to heart transplantation (HTx) patients with cardiogenic shock; however, alternative mechanical circulatory support (MCS) devices have been proposed with satisfactory results and, among those, paracorporeal systems have demonstrated to be safe and effective. This technology has been used for decades as bridge to transplant, especially in patients with advanced right ventricular dysfunction or evidence of multiorgan failure (MOF), which could be difficult to manage with an isolated left ventricular support. Paracorporeal systems are defined by having the pump located outside of the body, with inflow and outflow cannulas that traverse the skin connecting the pump with the heart and great vessels. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.01.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379185PMC
January 2019
1 Read

Extracorporeal membrane oxygenation for accidental deep hypothermia-current challenges and future perspectives.

Ann Cardiothorac Surg 2019 Jan;8(1):137-142

Department of Anesthesiology and Intensive Care Medicine, Medical University of Silesia, Katowice, Poland.

The incidence of accidental hypothermia (core temperature ≤35 °C) is difficult to estimate, as the affected population is heterogeneous. Both temperature and clinical presentation should be considered while determining severity, which is difficult in a prehospital setting. Extracorporeal rewarming is advocated for all Swiss Staging System class IV (hypothermic cardiac arrest) and class III (hypothermic cardiac instability) patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.10.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379186PMC
January 2019
1 Read

Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation.

Ann Cardiothorac Surg 2019 Jan;8(1):129-136

Department of Anesthesia and Pain Medicine, Hospital for Sick Children, University of Toronto, Toronto, Canada.

Unfractionated heparin (UFH) is the anticoagulant of choice during extracorporeal membrane oxygenation (ECMO) support. Despite its favorable pharmacologic properties, management of heparin anticoagulation during ECMO remains a major challenge. To date, little is known about the optimal monitoring strategy or the heparin dose offering the best safety/efficacy profile. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.07.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379198PMC
January 2019

Cardiac catheterization and percutaneous intervention procedures on extracorporeal membrane oxygenation support.

Ann Cardiothorac Surg 2019 Jan;8(1):123-128

Annette C. and Harold C. Simmons Transplant Institute, Baylor Scott & White Research Institute, Dallas, TX, USA.

Extracorporeal membrane oxygenation (ECMO) is used to support critically ill patients when conventional therapies have failed. ECMO has been available for four decades and has gained use as a rescue therapy in severe refractory hypoxic disorders and in patients with refractory cardiogenic shock (RCS). Over recent years, several percutaneous cardiac interventions and implant devices have been developed that are now used frequently in conjunction with ECMO in order to maintain organ perfusion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.11.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379180PMC
January 2019
2 Reads

Long-term survival and major outcomes in post-cardiotomy extracorporeal membrane oxygenation for adult patients in cardiogenic shock.

Ann Cardiothorac Surg 2019 Jan;8(1):116-122

Department of Cardio-Thoracic Surgery, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.

Extracorporeal membrane oxygenation (ECMO) in the veno-arterial (VA) configuration is an established method for the treatment of refractory cardiogenic shock. Such a condition characterizes the postoperative course of approximatively 1% of cardiac surgery patients. Although some studies have reported ECMO-related short-term results, little is known about the long-term outcomes of VA-ECMO therapy in the post-cardiotomy setting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379181PMC
January 2019
2 Reads

Extracorporeal membrane oxygenation support in pediatrics.

Ann Cardiothorac Surg 2019 Jan;8(1):109-115

Pediatric Cardiovascular Surgery, Pediatric Heart Center, Department of Surgery, University Children's Hospital Zurich, Zurich, Switzerland.

Extracorporeal membrane oxygenation (ECMO) is a general term that describes the short- or long-term support of the heart and/or lungs in neonates, children and adults. Due to favorable results and a steady decline in absolute contraindications, its use is increasing worldwide. Indications in children differ from those in adults. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.09.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379197PMC
January 2019
6 Reads

Extracorporeal membrane oxygenation as treatment of graft failure after heart transplantation.

Ann Cardiothorac Surg 2019 Jan;8(1):99-108

Department of Cardiovascular Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.

Heart transplantation (HTx) is a valuable option in eligible patients with end-stage heart failure. The most significant complication in the immediate post-operative period is early graft failure (EGF), with a mean incidence of 20-25%. EGF is a major risk factor for death and accounts for 40-50% of early mortality after HTx. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379182PMC
January 2019
1 Read

The Extracorporeal Life Support Organization Registry: update and perspectives.

Ann Cardiothorac Surg 2019 Jan;8(1):93-98

Department of Pediatrics, C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.

From the birth of the Extracorporeal Life Support Organization (ELSO) Registry in 1989, collecting the most relevant information about extracorporeal life support (ECLS) for refractory cardiac or respiratory compromise, was created in order to provide useful information and benchmark for ECLS users. Throughout the years, the Registry has continuously developed, achieving in 2018 more than 100,000 patients included with almost 500 ELSO centers around the world. Based on the relevance and impact of database analysis, and due to the growing need for more advanced and high-quality clinical investigations, the ELSO Registry is under substantial re-engineering which will allow and provide the ELSO members and the scientific community an enhanced scientific tool to elucidate various aspects of the ECLS settings, including trends and disease-specific information, to perform benchmarking about our own results and outcomes as compared to regional or worldwide results, and to provide an invaluable source of data for clinical investigations. Read More

View Article

Download full-text PDF

Source
http://www.annalscts.com/article/view/16562/16878
Publisher Site
http://dx.doi.org/10.21037/acs.2018.11.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379190PMC
January 2019
3 Reads

Role and management of extracorporeal life support after surgery of chronic thromboembolic pulmonary hypertension.

Ann Cardiothorac Surg 2019 Jan;8(1):84-92

Cardiac Surgery Department, Pulmonary Hypertension Unit, Bologna University, St. Orsola Hospital, Bologna, Italy.

Background: Pulmonary endarterectomy (PEA) is a surgical intervention reserved for patients with chronic thromboembolic pulmonary hypertension (CTEPH). In some cases, temporary circulatory support [extracorporeal life support (ECLS)] is required after PEA. Rates of ECLS requirement varies between centers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.01.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379184PMC
January 2019
3 Reads

Temporary mechanical circulatory support for refractory heart failure: the German Heart Center Berlin experience.

Ann Cardiothorac Surg 2019 Jan;8(1):76-83

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.

Background: Temporary mechanical circulatory support (MCS) offers a valuable option for treatment of refractory heart failure. We present our experience with selected MCS devices in cardiogenic shock of different etiologies.

Methods: We retrospectively studied patients who were treated in our institution between 01/2016 and 07/2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379195PMC
January 2019
2 Reads

Adult cardiac veno-arterial extracorporeal life support (VA-ECMO): prevention and management of acute complications.

Ann Cardiothorac Surg 2019 Jan;8(1):66-75

Advanced Cardiac Care and Transplant Institute, Integris Baptist Medical Center, Oklahoma City, OK, USA.

Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been shown to be a viable and effective treatment for patients suffering from refractory cardiogenic shock (rCS), which is associated with high mortality rates. Although ECMO therapy used as short-term mechanical circulatory support (MCS) has shown tremendous growth in its application over the past decade, the complication and mortality rates remain high. This retrospective study analyzes complications associated with VA-ECMO support, evaluates the use of defined protocols at a single center, and examines factors that may contribute to patient complication and mortality. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379202PMC
January 2019
1 Read

Inter-hospital transfer of extracorporeal membrane oxygenation-assisted patients: the hub and spoke network.

Ann Cardiothorac Surg 2019 Jan;8(1):62-65

Clinic for Thoracic- and Cardiovascular Surgery, Heart and Diabetes Centre North Rhine Westphalia, Bad Oeynhausen, Germany.

Background: The treatment of cardiogenic shock (CS) in peripheral hospitals may be challenging when acute mechanical circulatory support (MCS) is not available. Tertiary care centers may provide mobile extracorporeal membrane oxygenation (ECMO) teams to support the treatment of CS-patients externally.

Methods: We retrospectively analyzed our single-center experience with a mobile ECMO team focussing on decision-making and survival data of CS-patients retrieved by ECMO support from peripheral hospitals to our tertiary care center between January 2012 and October 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379188PMC
January 2019
9 Reads

Extracorporeal membrane oxygenation after lung transplantation: risk factors and outcomes analysis.

Ann Cardiothorac Surg 2019 Jan;8(1):54-61

Cardiac Surgery Division, Surgical Sciences Department, Città della Salute e della Scienza, University of Torino, Turin, Italy.

Background: Lung transplantation is the treatment of choice for end-stage pulmonary disease in selected patients. However, severe primary graft dysfunction is a significant complication of transplant and requires the implantation of an extracorporeal support. The aim of the study is to evaluate the impact of extracorporeal membrane oxygenation (ECMO) after transplant in our center. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379200PMC
January 2019
1 Read

Awake and fully mobile patients on cardiac extracorporeal life support.

Ann Cardiothorac Surg 2019 Jan;8(1):44-53

Division of Pulmonary, Allergy, and Critical Care, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, USA.

Early mobilization of critically ill patients is increasingly being recognized as not only safe and feasible, but also as a potential means of optimizing outcomes in the intensive care unit (ICU). With the rapidly expanding use of extracorporeal life support (ECLS) for severe cardiopulmonary failure, there is a growing interest in the application of early mobilization to this patient population, which has been shown to be safe and feasible in select patient populations. However, some patients receiving ECLS support may benefit more than others. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.08.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379193PMC
January 2019
1 Read

Temporary support strategies for cardiogenic shock: extracorporeal membrane oxygenation, percutaneous ventricular assist devices and surgically placed extracorporeal ventricular assist devices.

Ann Cardiothorac Surg 2019 Jan;8(1):32-43

Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, PA, USA.

The majority of clinical pathways and paradigms utilized in the treatment and management of cardiogenic shock with temporary mechanical circulatory support (MCS) are largely based on individual physician intuition and ad hoc problem-solving. Substantial mortality gains in the acute myocardial infarction cardiogenic shock (AMI-CS) population were observed with the reported outcomes of the SHOCK trial in 1999 compared to previous populations with AMI-CS. Nonetheless even in the age of percutaneous coronary intervention (PCI) of the infarct related artery, survival rates continue to be only approximately 50%. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.11.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379194PMC
January 2019
1 Read

Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes.

Ann Cardiothorac Surg 2019 Jan;8(1):19-31

Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, PA, USA.

Background: Heparin-induced thrombocytopenia (HIT) is a severe antibody-mediated reaction leading to transient prothrombosis. However, its incidence in patients on extracorporeal life support (ECLS) is not well described. The aim of this systematic review was to report the incidence of HIT in patients on ECLS, as well as compare the characteristics and outcomes of HIT in patients undergoing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and veno-venous ECMO (VV-ECMO). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379191PMC
January 2019
2 Reads

Left ventricular decompression in veno-arterial extracorporeal membrane oxygenation.

Ann Cardiothorac Surg 2019 Jan;8(1):9-18

Department of Cardiothoracic, Transplantation and Vascular Surgery, S. Orsola Hospital, Bologna University, Bologna, Italy.

Background: Despite the survival benefit of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for treatment of refractory cardiogenic shock, it can also have potentially deleterious effects of left ventricular overload and pulmonary edema. The objective of this review was to investigate the current evidence on the incidence, diagnosis, risk factors, prevention, and interventions for left ventricular overload in adult and pediatric VA-ECMO patients.

Methods: Five electronic databases, including MEDLINE, EMBASE, PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), and Cochrane Database of Systematic Reviews, were searched for original published studies from their dates of inception to January 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.11.07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379183PMC
January 2019
3 Reads

Outcomes of venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock: systematic review and meta-analysis.

Ann Cardiothorac Surg 2019 Jan;8(1):1-8

Department of Cardiovascular Surgery and Transplantation, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Background: Despite advances in management techniques and medical therapy, refractory cardiogenic shock remains a life-threatening condition with high mortality rates. The present systematic review and meta-analysis aims to explore the outcomes associated with venoarterial extracorporeal membrane oxygenation (VA-ECMO) use in the setting of refractory cardiogenic shock, stratified per survivorship.

Methods: A literature search was performed using three electronic databases from the date of their inception up to June 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.11.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379189PMC
January 2019
1 Read

Robotic mitral valve repair: standardized repair strategy ensures consistent results.

Ann Cardiothorac Surg 2018 Nov;7(6):837-838

Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.10.11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288223PMC
November 2018
2 Reads

LAMPOON transseptal mitral valve in ring.

Ann Cardiothorac Surg 2018 Nov;7(6):834-836

Divisions of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.10.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288208PMC
November 2018
1 Read

Minimally invasive transatrial mitral valve replacement in mitral annular calcification.

Ann Cardiothorac Surg 2018 Nov;7(6):827-829

Department of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center Houston, McGovern Medical School, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.10.07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288218PMC
November 2018
1 Read

Transcatheter mitral repair: MitraClip technique.

Ann Cardiothorac Surg 2018 Nov;7(6):824-826

Heart & Vascular Center, Valley Health System, Winchester, VA 22601, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.10.14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288210PMC
November 2018

Transcatheter trans-septal mitral valve-in-valve implantation.

Ann Cardiothorac Surg 2018 Nov;7(6):821-823

Division of Cardiothoracic Surgery, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.09.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288212PMC
November 2018
1 Read

Transapical NeoChord mitral valve repair.

Ann Cardiothorac Surg 2018 Nov;7(6):812-820

Department of Cardiology, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.

Transapical off-pump mitral valve repair (MVr) with NeoChord implantation has become widely applied in Europe for patients presenting with severe mitral regurgitation due to leaflet prolapse or flail. The procedure is performed under real-time 2D- and 3D-transesophageal echocardiography (TEE) for both implantation and neochordae tension adjustment allowing real-time monitoring of hemodynamic recovery. Preoperative anatomic and echocardiographic selection criteria, procedure refinement, as well as innovative ex-vivo surgical simulator training have been developed and strategically employed in the past few years, to generate a robust precision-based procedural framework with significantly enhanced operator use, patient safety and clinical outcomes. Read More

View Article

Download full-text PDF

Source
http://www.annalscts.com/article/view/16555/16841
Publisher Site
http://dx.doi.org/10.21037/acs.2018.11.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288219PMC
November 2018
8 Reads